David Vaczek, Author at MM&M - Medical Marketing and Media

David Vaczek

Most recent articles by David Vaczek

Can study data spur Merck CV sales?

Can study data spur Merck CV sales?

Merck said in November that a long-running clinical trial finally demonstrated the impact of its Zetia cholesterol-lowering treatment on cardiovascular outcomes. The results from the so-called IMPROVE-IT trial are expected to shore up Zetia/Vytorin sales, analysts said, after the first trial showing that a non-statin added to a statin reduces cardiovascular events. Doctors now may…